Blume-Jensen Peter - Insider Non-Derivative Transactions at Acrivon Therapeutics, Inc. (ACRV) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Aug 21, 2024, Blume-Jensen Peter's relationship to Acrivon Therapeutics, Inc. (ACRV) is Director,Officer (President and CEO), and currently has 2,422,513 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other ACRV insiders.
Data Source: SEC.
Blume-Jensen Peter - Insider Non-Derivative Transactions of ACRV Common Stock
Blume-Jensen Peter - Insider Non-Derivative Transactions at ACRV
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Aug 22, 2024 | F -- (Common Stock) | 79616 | 9.19 | 2422513 |
| Aug 15, 2024 | F -- (Common Stock) | 59765 | 7.02 | 2502129 |
| May 15, 2024 | F -- (Common Stock) | 54918 | 8.36 | 2561894 |
| Feb 15, 2024 | F -- (Common Stock) | 41861 | 3.4 | 2616812 |
| Nov 15, 2023 | F -- (Common Stock) | 239023 | 5.08 | 2658673 |
| Aug 22, 2023 | Acquisition -- (Common Stock) | 493994 | 0 | 2897696 |
| Jun 1, 2023 | M -- (Common Stock) | 33605 | 3.88 | 2403702 |